BioSpace News Archive

Alkermes plc (Nasdaq: ALKS) today announced that the company will accept applications for its Alkermes Inspiration Grants ® program beginning on May 1, 2023.

Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in medtech clinical trials. According to the 2023 Veeva MedTech Clinical Benchmark Report.

Glaukos Corporation today announced that it has published its 2022 Sustainability Report.

Castle Biosciences, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2023, after the close of market on Wednesday, May 3, 2023.

Sublime Radial Access Platform to include the industry’s first suite of torqueable peripheral microcatheters, designed for navigating tortuosity and crossing complex lesions and available for both transradial and transfemoral procedures.

ZAP Surgical Announces 1,000th Patient Treated with Its Groundbreaking ZAP-X Gyroscopic Radiosurgery Platform.

30 Technology, the world leader in clinical nitric oxide generation technology for health care, announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc.

Clinical Laserthermia Systems Americas, Inc., a leading provider of office-based, focal laser ablation systems for urologists, announced a Mobile Service Provider Agreement with AVANT Concierge Urology of Winterhaven, FL to begin using the CLS TRANBERG Thermal Therapy System to treat patients with low-to-intermediate stage prostate cancer.

Lytix Biopharma AS, a clinical stage immuno-oncology company, announces the election of a new Chairman of the Board at ‘s General Assembly.

BioArctic AB will publish the company’s first quarter report for January - March 2023 on Thursday, April 27, 2023, at 08:00 a.m. CET.